Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia.
Borja SantosEduardo González-FraileArantzazu ZabalaVirginia GuillénJosé R RuedaJavier BallesterosPublished in: Journal of psychopharmacology (Oxford, England) (2018)
The current evidence is too weak to base recommendations on the use of acetylcholinesterase inhibitors as adjunctive treatments to antipsychotics to improve basic cognitive functions. We have limited confidence in the effect estimates.
Keyphrases